Matches in Nanopublications for { ?s ?p "[It still needs to be clarified whether HER-2/neu overexpression increases the aggressiveness of carcinosarcoma, or whether HER-2/neu has a direct role in its pathogenesis, as described in breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP378851.RAz2833aXGgqC5D-rwnU_SbNApj4meUFKCaGH3H6YPYSg130_assertion description "[It still needs to be clarified whether HER-2/neu overexpression increases the aggressiveness of carcinosarcoma, or whether HER-2/neu has a direct role in its pathogenesis, as described in breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378851.RAz2833aXGgqC5D-rwnU_SbNApj4meUFKCaGH3H6YPYSg130_provenance.
- assertion description "[It still needs to be clarified whether HER-2/neu overexpression increases the aggressiveness of carcinosarcoma, or whether HER-2/neu has a direct role in its pathogenesis, as described in breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP495479.RAUEmmx7xT-jh3GRv6FOlwPnBvcZ4A17tQItSBnY3S7vU130_assertion description "[It still needs to be clarified whether HER-2/neu overexpression increases the aggressiveness of carcinosarcoma, or whether HER-2/neu has a direct role in its pathogenesis, as described in breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495479.RAUEmmx7xT-jh3GRv6FOlwPnBvcZ4A17tQItSBnY3S7vU130_provenance.
- NP495480.RAVnNEeimYrf139pfR2BdlwgE2VKwH9k--qPME5kZF_RU130_assertion description "[It still needs to be clarified whether HER-2/neu overexpression increases the aggressiveness of carcinosarcoma, or whether HER-2/neu has a direct role in its pathogenesis, as described in breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495480.RAVnNEeimYrf139pfR2BdlwgE2VKwH9k--qPME5kZF_RU130_provenance.